Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Getting ethical approval for research with children is important but can be complex and time-consuming, sometimes leading to the exclusion of certain age groups.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

Patients with alopecia areata face high costs for wigs due to poor insurance coverage.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Few dermatologists in Ontario accept OHIP referrals for hair loss, leading to long wait times and high fees.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Early detection and multidisciplinary treatment are crucial for managing Papillon-Lefévre syndrome.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Accurate diagnosis and management of rare genian fistulas require combined clinical, radiologic, and histopathologic evaluations.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Alopecia treatments are costly and often not covered by insurance, causing financial stress.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Facebook groups help patients using scalp cooling therapy by offering support, advice, and product recommendations.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.